ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,474
Screening encounters
4,036
Diagnostic referrals
774
Outstanding pathways
284

Screening pathway

  1. Screening4,036Encounters
  2. Positive finding1,382Documented findings
  3. Referral774Diagnostic referrals
  4. Follow-up899Diagnostic visits
  5. Outcome490Resolved pathways

Stage totals use different units. Pending pathways: 284. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0367 · EXP-0367Synthetic · Site A

Full participant history through 2026-09-13, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-10-05
  4. · Diagnostic referral · EXP-0367-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Appointment coordination
  8. · Barrier documented · Contact difficulty
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · No high-grade lesion identified
  14. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-06-27
  15. · Follow-up disposition · Resolved · EXP-0367-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

3474 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0387 · Expanded synthetic participant 0387Site D — Community Engagement Programme
EXP-0390 · Expanded synthetic participant 0390Site E — Resource-Constrained Navigation Programme
EXP-0391 · Expanded synthetic participant 0391Site C — Rural Outreach Programme
EXP-0392 · Expanded synthetic participant 0392Site C — Rural Outreach Programme
EXP-0393 · Expanded synthetic participant 0393Site D — Community Engagement Programme
EXP-0394 · Expanded synthetic participant 0394Site D — Community Engagement Programme
EXP-0396 · Expanded synthetic participant 0396Site A — Urban Referral Hub
EXP-0397 · Expanded synthetic participant 0397Site D — Community Engagement Programme
EXP-0399 · Expanded synthetic participant 0399Site B — Peri-Urban Access Programme
EXP-0401 · Expanded synthetic participant 0401Site E — Resource-Constrained Navigation Programme
EXP-0402 · Expanded synthetic participant 0402Site B — Peri-Urban Access Programme
EXP-0403 · Expanded synthetic participant 0403Site B — Peri-Urban Access Programme
EXP-0404 · Expanded synthetic participant 0404Site C — Rural Outreach Programme
EXP-0405 · Expanded synthetic participant 0405Site D — Community Engagement Programme
EXP-0406 · Expanded synthetic participant 0406Site D — Community Engagement Programme
EXP-0407 · Expanded synthetic participant 0407Site E — Resource-Constrained Navigation Programme
EXP-0408 · Expanded synthetic participant 0408Site B — Peri-Urban Access Programme
EXP-0409 · Expanded synthetic participant 0409Site E — Resource-Constrained Navigation Programme
EXP-0410 · Expanded synthetic participant 0410Site B — Peri-Urban Access Programme
EXP-0412 · Expanded synthetic participant 0412Site E — Resource-Constrained Navigation Programme
EXP-0413 · Expanded synthetic participant 0413Site E — Resource-Constrained Navigation Programme
EXP-0414 · Expanded synthetic participant 0414Site A — Urban Referral Hub
EXP-0417 · Expanded synthetic participant 0417Site D — Community Engagement Programme
EXP-0418 · Expanded synthetic participant 0418Site A — Urban Referral Hub
EXP-0419 · Expanded synthetic participant 0419Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1585
HPV DNA
1879
Cytology
572

Navigation activity

Barrier documented
680
Contact attempt
1135
Navigation intervention
286
Diagnostic booking
955
Diagnostic visit
899

Documented barriers

Contact difficulty
222
Transport difficulty
219
Appointment coordination
239

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.